Genmab Wraps Up Leveraged Finance’s Biggest M&A Deal Since April
{# Share Buttons Partial Variables: share_title — text to pre-fill in share dialogs share_url — canonical URL to share (use request.build_absolute_uri in parent) #}Market Intelligence Analysis
AI-Powered
Why This Matters
Genmab A/S completed a $4.5 billion acquisition funding deal, the largest in the US leveraged finance market since April, using junk bonds and a leveraged loan.
Market Impact
Market impact analysis based on bullish sentiment with 77% confidence.
Sentiment
Bullish
AI Confidence
77%
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Genmab A/S completed the US leveraged finance market’s largest acquisition funding since April, raising $4.5 billion through junk bonds and a leveraged loan.
Continue Reading
Full article on Bloomberg
Original article published by
Bloomberg
on November 19, 2025.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.